Results 81 to 90 of about 6,001 (210)
Journal of Interventional Cardiology, Volume 2026, Issue 1, 2026.Objective To evaluate the safety and efficacy of transapical implantation of a modified J‐Valve in patients with pure aortic regurgitation (AR) and large aortic annuli (> 29 mm). Methods This retrospective single‐center study included 10 high surgical risk patients (STS‐PROM: 8.3%–13.1%) with pure AR and annular diameters > 29 mm who underwent ...
Chunshui Liang +7 more
wiley +1 more source
, 2019 Supplemental material, Supplementary video 2, for Concomitant Transapical Transcatheter Aortic Valve Implantation and Transapical Mitral Valve Repair with NeoChord Implantation by Marie-Elisabeth Stelzmueller, Robert Zilberszac, Nikolaus Heinrich, Bruno ...
Nikolaus Heinrich (230809) +5 more
core +1 more source
Transaortic Transcatheter Aortic Valve Implantation as a second choice over the Transapical access [PDF]
, 2016 Background and Aims: In this report, we present our experience with the transaortic transcatheter aortic valve implantation using the SAPIEN valve. The procedural success, 30-day outcome, and survival up to 2years are compared with the transapical access
Vainikka, T. +5 more
core +1 more source
Journal of Interventional Cardiology, Volume 2026, Issue 1, 2026.Objectives We developed an exploratory computed tomography (CT)–based anatomical scoring system for the aortic root in pure aortic regurgitation (PAR), first performed a descriptive device‐level comparison between the on‐label J‐Valve cohort and the combined off‐label Venus A‐valve cohort, and then explored CT anatomical features associated with ...
Mei Liu +9 more
wiley +1 more source
Journal of Chest Surgery, 2022 Surgical septal myectomy is the preferred treatment option for patients with medically intractable obstructive hypertrophic cardiomyopathy. Extended transaortic septal myectomy is a widely performed surgical procedure for patients with subaortic ...
Dong Youb Han +2 more
doaj +1 more source
Journal of Interventional Cardiology, Volume 2026, Issue 1, 2026.Background and Aims Transcatheter aortic valve replacement (TAVR) is an innovative treatment option for patients with severe symptomatic aortic stenosis. However, an analysis of cerebrovascular risk post‐TAVR compared to surgical aortic valve replacement (SAVR) in elderly patients has not been established.
Jubran Al Hooti +4 more
wiley +1 more source
The Heart Surgery ForumBackground: Takayasu arteritis (TAK), a chronic inflammatory condition often leading to aortic dilation and regurgitation (AR), poses significant surgical challenges due to vascular fragility and calcification, increasing risks of ...
Beiyao Lu +6 more
doaj +1 more source
Journal of Interventional Cardiology, Volume 2026, Issue 1, 2026.Introduction Percutaneous pulmonary valve implantation (PPVI) has been approved for the management of the dysfunctional pulmonary valve (PV) and right ventricular outflow tract (RVOT). The study aimed to evaluate the feasibility, safety, and efficacy of the balloon‐expandable valves in PPVI for the management of dysfunctional different RVOTs with ...
Fatma Aboalsoud Taha +3 more
wiley +1 more source
Off-Pump Transapical Removal of An Embolized Transcatheter Aortic Valve
, 2017 Transcatheter aortic valve replacement is a less invasive alternative for high-risk patients. However, valve embolization is a rare but dreaded complication.
Lauren J. Taylor +4 more
core +1 more source
Transapical TMVI: Tendyne Valve
, 2023 This article is part of CTSNet’s Guest Editor Series, 21 Years After First TAVI: Will Pace of Innovations Continue for All Heart Valves? Guest editor Gry Dahle has curated a robust collection of content that shares the knowledge, techniques, and insights
Thomas Modine (7407067)
core +1 more source